Correlation Between Alkermes Plc and Shuttle Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alkermes Plc and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alkermes Plc and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alkermes Plc and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Alkermes Plc and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alkermes Plc with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alkermes Plc and Shuttle Pharmaceuticals.

Diversification Opportunities for Alkermes Plc and Shuttle Pharmaceuticals

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Alkermes and Shuttle is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Alkermes Plc and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Alkermes Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alkermes Plc are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Alkermes Plc i.e., Alkermes Plc and Shuttle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Alkermes Plc and Shuttle Pharmaceuticals

Given the investment horizon of 90 days Alkermes Plc is expected to generate 0.36 times more return on investment than Shuttle Pharmaceuticals. However, Alkermes Plc is 2.74 times less risky than Shuttle Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  2,614  in Alkermes Plc on August 31, 2024 and sell it today you would earn a total of  318.00  from holding Alkermes Plc or generate 12.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Alkermes Plc  vs.  Shuttle Pharmaceuticals

 Performance 
       Timeline  
Alkermes Plc 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Alkermes Plc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable forward-looking signals, Alkermes Plc is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Alkermes Plc and Shuttle Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alkermes Plc and Shuttle Pharmaceuticals

The main advantage of trading using opposite Alkermes Plc and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alkermes Plc position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.
The idea behind Alkermes Plc and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements